40 | ghp October 2016 Deals Durbin Appoints Todd Galles as Business Development Principal in US Durbin has made great strides in the US, thanks to a rapidly growing clinical trial supply and Managed Access business driven by its US acquisition last year, and recently won the UK Export Excellence Award for Export Excellence in the Americas. The appointment of Mr Galles reflects Durbin’s desire to continue its progress both in the US and globally. “Durbin has an important role to play in this global industry,” Mr Galles said. “To be a strong global player and industry leader in Europe, effective companies need to be strong in both the Americas and Europe. There are a lot of challenges to operating worldwide, but there are even more opportunities. As long as you’re flexible – which Durbin is – there’s a bright future if you can adjust your business to meet the evolving needs. “Durbin has made a huge resource commitment in the US, and I’m excited to help shape its growing operations here. The company recently opened a US facility in the Gulf Coast which adds customer service, regulatory support, warehousing and other services, further complimenting European operations. We are growing staff with a number of key new positions in the near-term in the US. I am delighted to be part of and play a big role in the US expansion.” Mr Galles continued, “Durbin is a champion of meet- ing unmet medical needs – it can distribute prod- ucts globally to treat patients in need and get them innovative medical therapy. No distribution challenge is too tough – if there’s a way, Durbin can provide the service. I’ve been so impressed by the service Durbin offers, and that was a big appeal to me. “To continue to develop the relationship between the US, Europe and the rest of the world is something I’m excited to be involved with. There are lots of small- and medium-sized companies that might need help making the jump to work in Europe and other regions around the world, and that’s something we can provide through our managed access programs (MAP). This is a prime example of a Durbin service that adapted to meeting marketplace needs. MAP service programs are delivering innovative therapies to patients with previously unmet medical needs all over the world. US expansion will play a key role in provid- ing enhanced global services for our clients.” Mr Galles has an extensive background in the life science industry more than 30 years of experience in sales, marketing, business development and executive management in the pharmaceutical and biotech fields. Previous companies include Syntex Laborato- ries, Dey LP, Santen, Genentech, BioMarin and Dow Pharmaceutical Sciences. Todd has also served on numerous industry and company advisory boards. Robert Donnell, head of business development at Durbin, commented on the appointment, “Todd has supported business development outreach in the US part-time for Durbin for more than two years, so now we’re delighted to have him on-board fulltime. Todd brings a huge amount of experience and enthusiasm to the role, and I look forward to continuing to work with him to develop and grow our US business.” www.durbin.co.uk Durbin, one of the world’s leading specialist medical suppliers and distributors of pharmaceuticals, has appointed Todd Galles to be its business development principal in the US. Mr Galles will be working to develop and grow Durbin’s client portfolio in the US.